TY - JOUR
T1 - Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries
T2 - Key messages from Disease Control Priorities, 3rd edition
AU - Disease Control Priorities-3 Cancer Author Group
AU - Gelband, Hellen
AU - Sankaranarayanan, Rengaswamy
AU - Gauvreau, Cindy L.
AU - Horton, Susan
AU - Anderson, Benjamin O.
AU - Bray, Freddie
AU - Cleary, James
AU - Dare, Anna J.
AU - Denny, Lynette
AU - Gospodarowicz, Mary K.
AU - Gupta, Sumit
AU - Howard, Scott C.
AU - Jaffray, David A.
AU - Knaul, Felicia
AU - Levin, Carol
AU - Rabeneck, Linda
AU - Rajaraman, Preetha
AU - Sullivan, Terrence
AU - Trimble, Edward L.
AU - Jha, Prabhat
N1 - Funding Information:
We thank George Alleyne for helpful comments on an earlier draft. The Bill & Melinda Gates Foundation provides financial support for the Disease Control Priorities Network project, of which this volume is a part. We received funding from the US National Cancer Institute, Canadian Institutes of Health Research (grant 126347), and Centre for Global Health Research.
Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/5/21
Y1 - 2016/5/21
N2 - Investments in cancer control - prevention, detection, diagnosis, surgery, other treatment, and palliative care - are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3% of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.
AB - Investments in cancer control - prevention, detection, diagnosis, surgery, other treatment, and palliative care - are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3% of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.
UR - http://www.scopus.com/inward/record.url?scp=84949024349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949024349&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(15)00755-2
DO - 10.1016/S0140-6736(15)00755-2
M3 - Review article
C2 - 26578033
AN - SCOPUS:84949024349
SN - 0140-6736
VL - 387
SP - 2133
EP - 2144
JO - The Lancet
JF - The Lancet
IS - 10033
ER -